Advertisement Pharmaceutical Business review - Page 230 of 5218 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 5, 2024

Genmab assumes full ownership of acasunlimab

Genmab has assumed the complete ownership of the acasunlimab development programme, including its continued development and potential commercialisation, contingent on approval.

Continue
BioNTech's decision to step back from the programme is claimed to be attributed to its portfolio strategy. Credit: Testalize.me on Unsplash.
August 2, 2024

Health Canada grants approval for Celltrion’s Steqeyma for multiple conditions

The treatment is authorised for use in adults with active Crohn's disease, plaque psoriasis, and active psoriatic arthritis. Credit: Eszter Miller from Pixabay.
August 1, 2024

Jade Biosciences secures $80m to develop autoimmune therapies

The company focuses on enhancing the standard of care for patients suffering from autoimmune diseases. Credit: Michal Jarmoluk from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. Pinetree secures $17m to advance TPD development programmes
  2. FDA approves Alpha Cognition’s ZUNVEYL for Alzheimer’s treatment
  3. LEO Pharma obtains positive EMA CHMP opinion for eczema treatment
  4. Confo Therapeutics secures €60m funds to progress GPCR-modulating therapies
  5. Oisín secures funds to advance treatments for age-related ailments

PRESS RELEASES

Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation